BUB: Infant Formula — The FDA Gamble

BUB · ASX:Bubs Australia has built a surprising foothold in the US infant formula market through a regulatory window that opened during the 2022 shortage crisis. We examine whether that foothold becomes perm...
1 / 6

BUB: Infant Formula — The FDA Gamble

💡

In a Nutshell

Executive Summary